Purpose of Review This review summarizes recent findings on mast cell biology with a focus on IgE-independent roles of mast cells in regulating allergic responses. Recent Findings Recent studies have described novel mast cell-derived molecules, both secreted and membrane-bound, that facilitate cross-talk with a variety of immune effector cells to mediate type 2 inflammatory responses. Summary Mast cells are complex and dynamic cells that are persistent in allergy and are capable of providing signals that lead to the initiation and persistence of allergic mechanisms.
Introduction
Mast cells are long-lived residential cells that protect against pathogens at barrier locations most vulnerable to the outside environment, such as the skin and mucosal surfaces [1] . Mast cells are "armed" with key mediators that induce inflammatory responses necessary to overcome infections by pathogens [2] . However, in some inflammatory disease settings, mast cells can mediate life-threatening reactions and/or chronic inflammation. In the context of allergy, dysregulation of the immune response occurs due to a break in immune tolerance to non-pathogenic antigens that leads to sensitization (i.e., production of antigen-specific IgE) of the immune system [3, 4] . Upon re-exposure to the same antigen, a Th2 (allergic) immune response is elicited. The typical immediate allergic response occurs through antigen-specific IgE that is bound to the high-affinity Fc receptor, FcεRI. The binding of antigen to IgE bound to FcεRI on mast cells leads to IgE cross-linking, and the selective release of a sequence of mediators, starting with preformed granules that contain histamine, proteases, cytokines, chemokines, and other mediators. Some of the clinical manifestations of this initial response include edema, increased vascular permeability, and smooth muscle contraction. Next, lipid mediators, such as prostaglandins and leukotrienes, are released. These mediators cause bronchoconstriction, mucus secretion, and respiratory mucosal edema in asthma. Finally, cytokines are released, which contributes to the recruitment of inflammatory cells such as eosinophils, basophils, and T cells, in the later phases of the allergic response [1] . In the last decade, mast cells have been described to facilitate novel interactions that both initiate and sustain allergic responses. In this review, we will highlight current findings describing how mast cells regulate key cellular mechanisms beyond these classical IgE-mediated responses, with a focus on cellular interactions and cross-talk with other inflammatory cells.
Non-IgE-Mediated Mast Cell Activation in Allergy
Studies on the role of mast cells in allergy have traditionally focused on mechanisms that are IgE-dependent; this is because the classical type 2 response is driven through IgE and mast cell activation. Therefore, IgE-independent roles of mast cells in allergic disease seemed less relevant. However, given the tissue-resident location of mast cells and their potential for rapid responses, IgE-independent roles of mast cells are likely to occur throughout the development of allergic disease, including periods prior to the production of allergen-specific IgE. It is well established This article is part of the Topical Collection on Basic and Applied Science that many allergic diseases are associated with defects in the epithelial barrier, which allows a variety of molecules, including allergens and microbial pathogen-associated molecular patterns (PAMPs), to access the underlying mucosal tissues [5, 6] . Mast cells express a variety of pattern recognition receptors, allowing them to respond to bacterial, viral, and fungal pathogens through Toll-like receptors (TLRs), C-type lectin receptors (CLRs), Nod-like receptors (NLRs), and retinoic acid-inducible gene-I-like receptors (RLRs) [7] . For example, Staphylococcal δ-toxin and Aspergillus fumigatus, organisms with strong associations to allergic diseases, have both been shown to mediate mast cell degranulation through activation of PRRs (Fig. 1) [8, 9] . Staphylococcus aureus colonization is associated with many allergic diseases, and it frequently colonizes the skin of patients with atopic dermatitis [10] . Staphylococcus aureus has been shown to activate human cord bloodderived mast cells through TLR2 and CD48, resulting in IL-8 and TGF-β secretion [11] . Aspergillus fumigatus is also known to be present in allergic airway disease [12] . In a recent study, IgE-independent mast cell degranulation was observed to be mediated through the CLR dectin-1 [13] , which also recognizes specific forms of Aspergillus fumigatus. This study demonstrated that a dectin-1 agonist could induce β-hexosaminidase and histamine release, however it remains unclear whether Aspergillus itself, through dectin-1, might induce mast cell activation and/or degranulation. Altogether, these studies suggest that mast cells can potentiate events in the allergic response cascade well before the production of IgE [14] . Understanding how mast cells may be activated and influence other immune cells prior to the production of allergen-specific IgE may provide new insights into the mechanisms that drive loss of tolerance and induction of allergic diseases.
The Role of Multiple Stimuli in Mast Cell Activation
It is also important to consider the effect of PRR stimulation in conjunction with IgE-mediated mast cell activation, since studies have demonstrated that certain PRR ligands can significantly influence subsequent mast cell mediator release. Simultaneous activation of murine and rat mast cells with a TLR2-ligand and FcεRI crosslinking has been shown to differentially affect cytokine production; for example, IL-6 release was enhanced in murine mast cells whereas IL-13 was suppressed in RBL-2H3 cells, a rat basophilic cell line often used as a surrogate for mast cells. Interestingly, both studies reported a suppression of degranulation as measured by β-hexosaminidase [15, 16] . In a recent study, human mast cells were simultaneously activated through FcεRI cross-linking and TLR2, TLR4, TLR5, TLR6, or TLR8 at low and high concentrations to determine whether this lead to enhanced cytokine release and degranulation. It was concluded that TLR4 enhanced production of GM-CSF, IL-5, IL-10, and IL-13 at high concentrations, while TLR6 activation enhanced IL-13 secretion. Activation of other TLRs, including TLR2, TLR5, and TLR8, along with IgE crosslinking did not seem to have any effect [17] .
Importantly, it is now becoming appreciated that activation through PRRs can also modulate the outcome of subsequent activation events, through a process termed innate memory [18] . Currently, this mechanism has been established for monocytes, macrophages, and natural killer cells [18] . Innate memory involves epigenetic changes following prior activation that lead to enhanced activation by the same or different stimuli [18] . Evolutionarily, the ability for innate cells to be trained based on prior pathogen interactions is likely beneficial to the host, for example, it has been shown that monocytes/macrophages previously exposed to C. albicans or β-glucan had enhanced responses to unrelated pathogens or PAMPS [18] . However, in the context of chronic inflammation in allergic diseases, this mechanism may be detrimental. To date, it has not been established whether mast cells are capable of obtaining innate memory. However, it has previously been shown that prolonged pretreatment of murine mast cells with TLR4 ligands enhanced subsequent IgE-mediated degranulation and secretion of leukotrienes [19] . This study suggests that mast cells in allergic disease may be initially activated in an IgE-independent fashion, which may alter the subsequent response to antigen-specific IgE cross linking. Altogether these studies demonstrate that the timing of activation, as well as the specific PRR that is activated, can greatly impact the outcome of mast cell activation. Mast cells are sensitive to their environment and develop different signatures depending on their micro-environment in tissues, such as mucosal mast cells vs connective tissue mast cells [1] . In allergic disease, mast cells are exposed to conditions of constant inflammation and activation that have the potential to alter their responses. Understanding the signature of mast cells in patients with allergic disease could also provide insight on potential mediator targets and mechanisms that exacerbate disease or promote the development of additional allergic manifestations.
Mast Cells and T Cells
There are key events necessary for the development of allergic sensitization, including processing of allergen by antigen presenting cells, development of Th2 cells in the presence of early IL-4 or IL-13, and cellular interactions of B cells and T cells to induce IgE class-switching in the presence of IL-4 and IL-13 [20••] . Studies in mast cell-deficient mice demonstrate that the necessity of mast cells on these events depends on the antigen. For example, in models of IgE-mediated lung inflammation and skin sensitization by OVA, mast cells are not necessary for induction of IgE responses nor IgE levels in the serum [21] . Conversely, in house dust mite-induced inflammation in the lung, mast cells are necessary to induce WT levels of IgE in the serum but not some local inflammatory responses [22] .
Emerging evidence demonstrates that mast cells are able to provide signals that can potentially initiate and sustain T cell priming events (Fig. 1) . The priming of naïve T cells toward a Th2 phenotype occurs through a process of direct and indirection stimulation provided by dendritic cells in conjunction with IL-4. The initial source of IL-4 during Th2 priming is unclear, but Th2 cells [23] and basophils [24] have been shown to be potential sources of IL-4 during Th2 skewing. Although there is evidence that mast cells express IL-4 at the mRNA level in response to stimuli such as IgE, IL-33, and lectins [25] , secretion of IL-4 by mast cells has not been fully characterized. Likewise, the ability of mast cells to act as antigen-presenting cells has been the subject of debate in the literature [26] . Antigen-presenting cells must present antigen via MHC class II along with costimulatory signals, such as CD80, in order to efficiently activate naïve T cells [27] . Interestingly, in a recent study, human mast cells from skin were shown present antigen to autologous CD4 + T cells, and mast cell proteases were shown to be responsible for processing antigen for presentation to T cells [28] . It was also shown that mast cell expression of MHC class II and the co- and mast cell mediators, including histamine, play a role in antigenspecific antibody production. IL-9 provides a link between T cells, B cells, and mast cells, and it has been shown to be necessary for the generation of memory B cells in germinal centers, as well as mast cell accumulation in allergy. (lower left) The interface of these interactions can occur in areas of local inflammation, including nasal tissues, nasal polyps, and bronchial mucosa where local IgE production can be sustained and drive inflammation stimulatory molecules CD40 and CD80 was dependent on IFN-γ [28] . This suggests that mast cells could play a role in sustaining activation of memory Th2 cells at sites of allergic inflammation during chronic allergic inflammation.
More recently, studies have begun to focus on the potential role for mast cell exosomes in T cell activation (Fig. 1) . These secreted vesicles have been shown to express membrane proteins that can activate T cells [29••] . One of the first studies to demonstrate a role for exosomes in T cell activation found that exosomes isolated from IL-4-treated bone marrow-derived mast cells could induce proliferation of splenocytes in vitro [29••] . These exosomes expressed MHC class II, CD86, CD49, CD40L, LFA-1, and ICAM-1, all of which are known to play a role in T cell activation. A separate study has also shown that exosomes isolated from bone marrow derived mast cells could enhance the frequency of Th2 cell differentiation in the presence of IL-4 when compared to T cells cultured in IL-4 alone, and this was dependent on OX40L-OX40 interactions [30••] . Although there are only a few studies supporting the role for exosomes in allergic mechanisms, it is clear that they have the potential to provide signals to enhance T cell proliferation and Th2 differentiation. Further studies are needed to determine whether exosomes from PRR-activated or IgEprimed mast cells could provide unique signals for T cell activation.
Mast Cells and B Cells
Classically, IgE has provided the link between mast cells and B cells. However, there is evidence that mast cells have the potential to contribute to B cell differentiation, antibody production, and survival ( Fig. 1) [31] . In vitro studies demonstrated that IgE-activated mast cells enhance the proliferation and differentiation of both naïve and activated B cells [32, 33] . In these studies, it was demonstrated that cell contact was only partially necessary for B cell activation, indicating that secreted mast cell mediators may also directly stimulate B cells. In another study it was shown that CD40/CD40L interactions were driving the cross-talk between mast cells and B cells [33] . In addition, it was shown that CD40L expression on mast cells was regulated by a cross-linking enzyme, TGase 2, which is also upregulated in allergic asthma [34] . The mediator TGase 2 was shown to enhance IgE production by B cells in a murine model airway hypersensitivity, and in vitro mast cells required TGase 2 to induce CD138 expression on, and IgE production by, B cells. The role for mast cell mediators in B cell responses has not been well studied in allergic disease. One of the major mediators of mast cells is histamine, an active amine derived from histidine through a decarboxylation reaction by histamine decarboxylase (HDC). Histamine is prominently stored in granules in mast cells and basophils. Studies utilizing HDC knock-out (KO) mice, which cannot synthesize histamine, demonstrated that histamine deficiency resulted in reduced inflammation and reduced allergen-specific IgE production in a model of allergic airway inflammation [35] . In allergic responses, histamine primarily mediates it effects via the histamine receptors 1, 2, and 4, while the histamine 3 receptor is confined mainly to the central nervous system [36] . Studies by our group using histamine 2 receptor KO mice suggest that histamine is necessary for antibody production in a model of allergic airway inflammation, supporting early conclusions of this nature [37, 38•] . Conversely, histamine receptor 1 KO mice had enhanced antibody production [37] . Further studies are needed to fully characterize the role for histamine receptors 1 and 2 in antibody production and B cell activation, since evidence indicates both T cells [37] and B cells [39] may have intrinsic mechanisms that facilitate antibody production though histamine.
Germinal Centers and Mast Cells
Germinal center formation is an orchestrated series of events leading to development of high-affinity antibodysecreting plasma cells and memory B cells. The formation of germinal enter B cells is driven by cellular interactions with T follicular helper cells [40] . The potential role for cells such as mast cells in the regulation of germinal center responses has not been well studied, either in secondary lymphoid organs, or in the formation of tertiary lymphoid structures at sites of inflammation. One potential mast cell mediator that could have an effect on the germinal center reaction is IL-9 (Fig. 1) . Mast cells and IL-9 have been shown to be important factors in atopic dermatitis [41] , allergic asthma [42] , and food allergy [43] . Interestingly, it was recently shown that germinal center development of memory B cells was driven by IL-9 produced by follicular helper T cells [44] , which play a variety of roles in the formation and maintenance of germinal centers [40] . Moreover, a newly described subset of Th2 cells characterized as CD24d + CD161 + CRTH2 + , called TH2A cells, have also been associated with allergic disease, and they express significantly more IL-9 compared to conventional Th2 cells [45••] . Finally, it has been shown that Th9 cells were required for tissue mast cell accumulation during allergic inflammation [46] . Altogether, these studies suggest that IL-9 may play a role in bridging mast cell responses and B cell activation and antibody production in allergic disease, although more studies are needed to determine whether this occurs in vivo.
Role for Local IgE Production
Interestingly, serum IgE levels do not always indicate the severity of allergic disease in atopic dermatitis [47] , allergic asthma [48] , and food allergy [49] . This suggests that perhaps local production of IgE at sites of inflammation may be more relevant to disease severity. In line with this, treatment of IgEmediated diseases with omalizumab, a humanized monoclonal anti-IgE antibody, has shown efficacy both in patients with high serum IgE levels and patients with low/undetectable levels of serum IgE [50, 51•] . In addition, Dr. Locksley's group has shown that free IgE is taken up from the serum directly by mast cells in the tissue [52•] ; therefore, any IgE that is present in the serum may be "left over" and thus serum IgE levels do not indicate true IgE levels. Numerous studies have also shown increased tissue IgE levels compared to serum, including in the lung [53] and nasal polyps [54] . Finally, there is evidence indicating that class-switching to IgE occurs in the bronchial mucosa [55] , nasal tissues [56] , and nasal polyps [54] . This local production of IgE has the potential to influence cellular interactions between adaptive cells, such as T cells and B cells, and innate effector cells, such as mast cells that are present in the tissue (Fig. 1) . In addition, it is possible that mast cells themselves may play a key role in the local activation of B cells and secretion of IgE.
Conclusion
Mast cells are robust mediators of the pathological manifestations of allergy through IgE cross-linking of FcεRI. However, mast cells function through a variety of mechanisms that go beyond edema, cell infiltration, and vascular constriction. The plethora of mediators and receptors expressed by these tissueresident cells allows them to communicate with a variety of different cells through multiple mechanisms, and thus create an interface between innate and adaptive responses that has the potential to initiate and sustain the inflammatory events of allergic disease.
